The following sections explain scenarios where active substances have a different status in the EU compared to Great Britain (GB).
After 1 March 2028, the regulatory positions for these active substances will change.
The guidance below explains any impacts that the SPS Agreement will have on these scenarios. You may also wish to read existing guidance to understand what the status means and how to put products on the market. If you have any specific questions you can email [email protected].
If you have Biocidal Products Regulation (BPR) product authorisations, Control of Pesticides Regulations (COPR) product approvals or on-going applications we will contact you before 1 March 2028. If you have not been contacted, email [email protected].
This guidance is intended to help businesses prepare for implementation of the SPS Agreement. Details remain subject to legislative processes.
1. EU status is not approved
All the active substance/product type combinations in this scenario have received a non-approval decision in the EU since 1 January 2021.
On 1 March 2028 these active substance/product type combinations will become non-approved in GB. This means that products containing these active substances will have to be removed from the GB market.
The following GB statuses have been identified:
1a. GB status is under review
In GB these active substances are currently under review for the listed product types by HSE as part of the GB Review Programme and may be used in biocidal products, subject to national rules.
The affected active substance/product type combinations are in tab ‘Scenario 1a’ of the SPS list of biocide active substances
Biocidal products containing these active substance/product type combinations can no longer be supplied in GB after 31 May 2028 or used in GB after 30 November 2028. This includes products that currently have COPR approval and products that may currently be made available on the GB market without GB BPR authorisation. During this transition period you should still comply with any applicable requirements of COPR, other national law and the relevant parts of BPR.
Articles treated with biocidal products containing these active substance/product type combinations will no longer be allowed to be placed on the market in GB after 31 August 2028. Existing treated articles already in the supply chain before this date can continue to be made available and used in GB.
Affected businesses should take steps now to ensure these deadlines are met. HSE cannot extend or alter them. If you believe any of these active substance/product type combinations are critical and no suitable alternative is available, email [email protected] as soon as possible.
1b. GB status is under assessment
In GB the active substance is currently under assessment for the listed product types by HSE and cannot currently be used in biocidal products in GB, therefore there should not be any products containing these active substances on the market.
Some substances within this group are allowed to be used in treated articles in accordance with Article 94.
The affected active substance/product type combinations are in tab ‘Scenario 1b’ of the SPS list of biocide active substances
After 1 March 2028 biocidal products containing these active substance/product type combinations cannot be made available on the GB market.
Articles treated with biocidal products containing these active substance/product type combinations may no longer be placed on the market in GB after 31 August 2028. Existing treated articles already in the supply chain before this date can continue to be made available and used in GB.
Affected businesses should take steps now to ensure this deadline for treated articles is met. HSE cannot extend or alter it. If you believe any of these active substance/product type combinations are critical and no suitable alternative is available, email [email protected] as soon as possible.
1c. GB status is application withdrawn
For these active substance/product type combinations, the application for an active substance was withdrawn by the applicant under GB BPR. This means biocidal products, or articles treated with the active substance/biocidal product, cannot currently be made available on the GB market.
The affected active substance/product type combinations are in tab ‘Scenario 1c’ of the SPS list of biocide active substances
After 1 March 2028 there will be no change to the current position. It will still be the case that biocidal products containing these active substance/product type combinations cannot be made available on the GB market.
2. EU status is expired
The status ‘expired’ means that the active substance approval has expired for the listed product types as it has not been renewed under EU BPR. These active substances cannot be used in biocidal products for those product types in the EU. The status ‘expired’ means either that the renewal application was not submitted, or that an application was submitted but a decision was taken to not renew the approval.
Within this scenario, to date almost all identified active substances have expired in the EU following non-renewal decisions.
As an exception to this, the active substance/product type combinations in scenario 2b were approved in the EU in 2021, however expired following lack of support for the renewal. The statuses are therefore EU expired and GB not approved, which is slightly different to scenario 15 (both not approved) and 16 (both not expired).
The following GB active substance statuses have been identified:
2a. GB status is approved under renewal
This means that biocidal products containing these active substances in the relevant product types typically need product authorisations to be on the GB market.
In GB, biocidal products containing these active substances which are allowed on the market, can be used in treated articles.
In the EU, the active substance/product type combinations in this scenario have expired following non-renewal decisions.
The affected active substance/product type combinations are in tab ‘Scenario 2a’ of the SPS list of biocide active substances
After 1 March 2028 these active substances will have the status ‘expired’ in GB. This means that products containing these active substances will have to be removed from the GB market.
Where a product is authorised under GB BPR or regulated under existing national rules (COPR), HSE will contact authorisation holders/applicants to cancel authorisations or reject applications and to outline any applicable periods of grace.
Articles treated with biocidal products containing these active substance/product type combinations will no longer be allowed to be placed on the market in GB after 31 August 2028. Treated articles already in the supply chain before this date can continue to be made available and used in GB.
Affected businesses should take steps now to ensure the deadlines are met. HSE cannot extend or alter them. If you believe any of these active substance/product type combinations are critical and no suitable alternative is available, email [email protected] as soon as possible.
2b. GB status is not approved
In GB, this status means that the active substance is not approved for use in biocidal products of the listed product types in GB following a non-approval decision.
Products containing these active substance/product type combinations should not be currently supplied in GB.
The affected active substance/product type combinations are in tab ‘Scenario 2b’ of the SPS list of biocide active substances
After 1 March 2028 products containing these active substance/product type combinations will continue to not be allowed to be made available on the GB market.
3. EU status is cancelled
This status is where an active substance approval has been cancelled for the listed product types following a review under EU BPR. This active substance cannot be used in biocidal products in the EU. The ECHA active substance database uses the status ‘expired’.
The following GB status has been identified:
3a. GB status is approved
This means in GB, biocidal products containing these active substances in these product types should typically have product authorisation to be on the GB market.
In GB, biocidal products allowed on the market containing these active substances can be used in treated articles.
The affected active substance/product type combinations are in tab ‘Scenario 3a’ of the SPS list of biocide active substances
In the EU, the active substance/product type combination in this scenario has expired following cancellation of the approval under EU BPR since 1 January 2021.
It is noted the expiry date for the affected active substance/product type combination is 31 December 2027, and therefore the approval will expire in GB before the SPS Agreement applies.
4. EU status is under assessment
The active substance/product type combinations in this scenario are ‘under assessment’ in the EU. This means that the active substance is being evaluated and has not yet received a decision on approval. Biocidal products containing these active substances cannot be made available on the market, and as within this scenario the active substances are new, there are no derogations that apply.
From 1 March 2028 this status will apply to these active substance/product type combinations in GB.
The following GB active substance status has been identified:
4a. GB status is application withdrawn
For these active substance/product type combinations, the application for a new active substance was withdrawn by the applicant under GB BPR. This means currently you cannot make biocidal products containing this active substance available on the GB market.
The affected active substance/product type combinations are in tab ‘Scenario 4a’ of the SPS list of biocide active substances
On 1 March 2028 the status will change to ‘under assessment’ for these active substance/product type combinations in GB. However, as these are new active substances this means that biocidal products containing these active substances still cannot be made available on the market as a relevant derogation does not apply.
All decisions on approval taken by the EU Commission will be published in the Official Journal (EUR-Lex). HSE ebulletins will also be sent to inform stakeholders of the decision.
If a decision on approval is taken in the EU, it will apply in GB on 1 March 2028.
This will result in your active substance changing scenario. You should therefore monitor the EU status regularly. You can do this by checking SPS list of biocide active substances or ECHA’s website.
These active substances cannot be used to treat articles in GB until the active substances have been approved under EU BPR and GB authorisation has been granted for the biocidal product.
5. EU status is approved or approved under renewal
All the active substance/product type combinations in this scenario are approved in the EU. Some of the active substances have the status ‘approved under renewal’ where renewal applications have been made, this however does not impact the availability and regulation of biocidal products being placed on the market.
Before the application date of the SPS Agreement (1 March 2028), it is possible that the EU will make renewal decisions, so the EU status could change from approved under renewal to approved or to another status, and restrictions or requirements may apply and impact biocidal products or treated articles in GB. You should monitor the status of your active substance/product type combination regularly.
Product authorisation applications
On 1 March 2028 these active substances will become approved in GB. This means that BPR product authorisation applications may be needed, or existing GB authorisations may need to be changed. Further details about how to apply via the EU system will be provided when available.
The scenarios below will outline any deadline for these applications as the date of approval for the active substance might be in the past. Where the date of approval in the EU decision is before 1 March 2028, applications should be submitted by 31 August 2028.
Where the date of approval in the EU decision is after 1 March 2028, applications should be submitted by the date of approval.
Whether you can supply or continue to supply the biocidal product in GB will be outlined in the specific scenario information.
The following GB active substance statuses have been identified:
5a. GB status is under review
In GB the active substances are currently ‘under review’ for the listed product types by HSE as part of the GB Review Programme and may be used in biocidal products, subject to national rules.
The affected active substance/product type combinations are in tab ‘Scenario 5a’ of the SPS list of biocide active substances
After 1 March 2028, BPR authorisation is required to maintain market access. Applications for authorisation must be made to HSE. If the date of approval in the EU decision is before 1 March 2028, applications should be submitted by 31 August 2028. If the date of approval in the EU decision is after 1 March 2028, applications should be submitted by the date of approval. Further details about how to apply under the EU system will be provided when available.
During the application and evaluation process, products will remain subject to existing GB national rules, for example COPR.
Articles treated with biocidal products containing these active substance/product type combinations can continue to be placed on the market. However, all treated articles placed on the market after 31 August 2028 must comply with any restrictions or specific labelling conditions imposed by the approval or renewal decision.
If you want to bring a new product within scope of COPR to the market, you should apply for COPR approval by at least 6 months before the deadline to submit your BPR product authorisation application otherwise you will have to wait until the BPR authorisation is granted before you could bring the product to the market.
5b. GB status is under assessment and the regulatory process is ‘Article 93’
In GB, these active substances are currently ‘under assessment’ for the listed product types by HSE under GB BPR, but not as part of the GB Review Programme. As the regulatory process is ‘Article 93’ the active substances fall under the transitional measures of Article 93 of GB BPR.
These active substances can be used in biocidal products in GB subject to national rules.
The affected active substance/product type combinations are in tab ‘Scenario 5b’ of the SPS list of biocide active substances
After 1 March 2028, BPR authorisation is required to maintain market access. Applications for authorisation must be made to HSE. If the date of approval in the EU decision is before 1 March 2028, applications should be submitted by 31 August 2028. If the date of approval in the EU decision is after 1 March 2028, applications should be submitted by the date of approval. Further details about how to apply under the EU system will be provided when available.
During the application and evaluation process, products will remain subject to existing GB national rules.
5c. GB status is notified
In GB, these active substances have been successfully notified for support for the listed product types in the GB Review Programme, following participant withdrawal. These active substances can be used in biocidal products in GB subject to national rules.
The affected active substance/product type combinations are in tab ‘Scenario 5c’ of the SPS list of biocide active substances
After 1 March 2028, BPR authorisation is required to maintain market access. Applications for authorisation must be made to HSE. If the date of approval in the EU decision is before 1 March 2028, applications should be submitted by 31 August 2028. If the date of approval in the EU decision is after 1 March 2028, applications should be submitted by the date of approval. Further details about how to apply under the EU system will be provided when available.
During the application and evaluation process, products will remain subject to existing GB national rules, such as COPR.
Articles treated with biocidal products containing these active substance/product type combinations can continue to be placed on the market. However, all treated articles placed on the market after 31 August 2028 must comply with any restrictions or specific labelling conditions imposed by the approval or renewal decision.
If you want to bring a new product within scope of COPR to the market, you should apply for COPR approval by at least 6 months before the deadline to submit your BPR product authorisation application otherwise you will have to wait until the BPR authorisation is granted before you could bring the product to the market.
5d. GB status is approved under renewal (active substance approved in EU)
In GB, these active substances are ‘approved under renewal’ for the listed product types, and the approval has already been renewed in the EU. This means that biocidal products containing these active substances should typically be authorised before being placed on the GB market.
The affected active substance/product type combinations are in tab ‘Scenario 5d’ of the SPS list of biocide active substances
On 1 March 2028, these active substances will have the status ‘approved’ as the active substances have been renewed in the EU. The renewal will apply in GB. This means that any conditions or restrictions of the renewal must be complied with in GB.
Where a product is authorised under GB BPR or an application is ongoing, HSE will contact authorisation holders/applicants to inform them of any changes needed to their authorisations/applications. Where authorisations/applications cannot be changed or authorisation holders/applicants do not wish to make changes, HSE will cancel/reject authorisations/applications and inform authorisation holders/applicants of any applicable periods of grace.
Where affected biocidal products still hold a COPR approval, HSE will contact approval holders regarding any amendments or revocations.
Articles treated with biocidal products containing these active substance/product type combinations can continue to be placed on the market. However, all treated articles placed on the market after 31 August 2028 must comply with any restrictions or specific labelling conditions imposed by the approval or renewal decision.
5e. GB status is approved (renewal not supported in GB)
In GB, active substance renewal applications for the listed product types were not submitted. The active substance approvals will expire in GB.
The affected active substance/product type combinations are in tab ‘Scenario 5e’ of the SPS list of biocide active substances
If the EU does not take any decisions for the affected active substances before 1 March 2028:
- Where the active substance GB expiry dates are before 1 March 2028, the status will change to ‘expired’ in GB. At this point when the status changes, active substance/product type combination will move to scenario 5i (EU approved under renewal and GB expired).
- Where the active substance GB expiry dates are after 1 March 2028, the status will change to approved under renewal on 1 March 2028 and market access can continue in accordance with the BPR product authorisation (or pending applications and national rules).
It is however possible that the EU will make renewal decisions, so the EU status could change from approved under renewal to approved or to another status. You should monitor the status of your active substance/product type combination regularly.
5f. GB status is under assessment and the regulatory process is ‘new’ and ‘existing non-review’
In GB, these active substances are ‘under assessment’ for the listed product types by HSE under GB BPR, but not as part of the GB Review Programme. As the regulatory processes are either ‘new active substance’ or ‘non-review programme existing active substance’ these active substances cannot currently be used in biocidal products in GB, therefore there should not be any products containing these active substances on the market.
The affected active substance/product type combinations are in tab ‘Scenario 5f’ of the SPS list of biocide active substances
Before 1 March 2028 products containing these active substance/product type combinations should not be supplied. After 1 March 2028 if you want to supply biocidal products containing any of these active substance/product type combinations you must apply for BPR product authorisation. Note you only need to apply for BPR product authorisation once the last active substance/product type combination in your product has been approved. Further details about how to apply via the EU system will be provided when available. Products must not be supplied and/or used until product authorisation is granted.
5g. GB status is not approved
In GB, this status means that the active substance is not approved for use in biocidal products of the listed product types following a non-approval decision.
Products containing these active substance/product type combinations should not be currently supplied in GB unless they are in a phase-out period.
The affected active substance/product type combinations are in tab ‘Scenario 5g’ of the SPS list of biocide active substances
If you want to supply biocidal products containing any of these active substance/product type combinations after 1 March 2028 you must apply for BPR product authorisation. Further details about how to apply via the EU system will be provided when available. Note you only need to apply for BPR product authorisation once the last active substance/product type combination in your product has been approved.
Guidance on the applicability of Article 89 transitional provisions while awaiting BPR product authorisation will be communicated when available.
5h. GB status is not included (simplified active substance)
In GB, these active substances would not be included as simplified active substances on the GB tab of the BPR active substance lists for GB and NI. They may however be listed as review programme active substances for certain product types. More information for each active substance is provided below.
Products may be on the market containing these active substances.
The affected active substance/product type combinations are in tab ‘Scenario 5h’ of the SPS list of biocide active substances
For citric acid – in GB this active substance is currently ‘approved under renewal’ for PT2, and ‘not approved’ for PTs 1 and 3. This means that products may be on the market for PT2 only, either having a BPR product authorisation or under national rules while an evaluation is on-going. In the EU it is likely that the PT2 approval will expire leaving only the simplified listing.
New products containing citric acid could be granted national, union or simplified authorisation or made available on the market through a simplified notification.
Existing product authorisations for PT2 granted in accordance with GB BPR can continue.
For nitrogen generated from ambient air – this active substance has never been supported under GB BPR and therefore products containing this in-situ generated active substance should not currently be being used. If you want to generate this active substance and use it as a biocide you must apply for BPR product authorisation or submit a simplified notification and wait until the product authorisation is granted or the notification process is complete.
In both cases, after 1 March 2028, a simplified notification (ECHA website) will now be a possible application type in GB. Details about how to submit a notification will be provided when available.
5i. GB status is expired
In GB the status ‘expired’ means that the active substance approval has expired for the listed product types as it has not been renewed under GB BPR.
Products containing these active substance/product type combinations should not be currently supplied in GB unless they are in a period of grace.
The affected active substance/product type combinations are in tab ‘Scenario 5i’ of the SPS list of biocide active substances
Products containing these active substance/product type combinations should not have valid BPR authorisations. The authorisations will have been cancelled however existing stock may continue to be supplied in the period of grace.
For GB BPR authorised products still on the market under a GB period of grace or that previously held authorisation, we will contact you to discuss reinstating the authorisation. For other products not yet requiring BPR product authorisation, guidance on the applicability of Article 89 transitional provisions while awaiting BPR product authorisation will be communicated when available.
If you want to supply new biocidal products containing any of these active substance/product type combinations you must apply for BPR product authorisation. Note you only need to apply for BPR product authorisation once the last active substance/product type combination in your product has been approved. Further details about how to apply via the EU system will be provided when available.
5j. GB status is application withdrawn
This status in GB means that the application for a new active substance for the listed product types was withdrawn by the applicant under GB BPR. This active substance cannot currently be used in biocidal products in GB, therefore currently there should not be any products containing these active substances on the market in GB.
The affected active substance/product type combinations are in tab ‘Scenario 5j’ of the SPS list of biocide active substances
After 1 March 2028, if you want to supply biocidal products containing any of these active substance/product type combinations you must apply for BPR product authorisation. Biocidal products must not be supplied until product authorisation is granted. Further details about how to apply via the EU system will be provided when available.
6. EU status is under review
This means currently these active substances are ‘under review’ for the listed product types as part of the EU BPR Review Programme and may be used in biocidal products.
On 1 March 2028 these active substances will become ‘under review’ in GB. This means that products containing active substances for the relevant product type can be made available on the market, subject to national rules.
The following GB active substance statuses have been identified:
6a. GB status is no longer supported
This means in GB biocidal products containing active substances that are no longer supported for the relevant product type can continue to be made available on the market, until a GB non-approval decision is published. Due to the SPS Agreement, we do not expect any GB BPR non-approval decisions to be made for these active substances.
The affected active substance/product type combinations are in tab ‘Scenario 6a’ of the SPS list of biocide active substances
On 1 March 2028 these active substances will become ‘under review’ in GB. This means that products containing active substances for the relevant product type can continue to be made available on the market, subject to national rules.
6b. GB status is notified
This means in GB biocidal products containing any active substances that are notified for the relevant product type can continue to be made available on the market, subject to national rules.
The affected active substance/product type combinations are in tab ‘Scenario 6b’ of the SPS list of biocide active substances
On 1 March 2028 these active substances will become ‘under review’ in GB. This means that products containing active substances for the relevant product type can continue to be made available on the market, subject to national rules.
If you are currently a GB BPR notifier for an active substance, this does not automatically make you a notifier/participant for that active substance in the EU Review Programme. If you want to become a participant in the EU Review Programme, you will need to follow the relevant EU process such as joining or replacing a participant.
If you are the GB BPR notifier we will contact you regarding any further actions required.
6c. GB status is not approved
In GB, this status means that the active substance is not approved for use in biocidal products of the listed product types following a non-approval decision.
Products containing these active substance/product type combinations should not be currently supplied in GB unless they are in a phase-out period.
The affected active substance/product type combinations are in tab ‘Scenario 6c’ of the SPS list of biocide active substances
On 1 March 2028 these active substances will become ‘under review’ in GB. This means that products containing active substances for the relevant product type can be made available on the market subject to national rules.
Guidance on the applicability of Article 89 transitional provisions will be communicated when available.
7. EU status is no longer supported
All the active substance/product type combinations in this scenario are no longer supported in the EU Review Programme and are expected to receive non-approval decisions at some point in the future.
On 1 March 2028 these active substances will become ‘no longer supported’ in GB. This means that products containing active substances that are no longer supported for the relevant product type can continue to be made available on the market subject to national rules until a non-approval decision is made.
The following GB active substance statuses have been identified:
7a. GB status is not approved
In GB, this status means that the active substance is not approved for use in biocidal products of the listed product types following a non-approval decision. Products containing these active substance/product type combinations should not be currently supplied in GB.
The affected active substance/product type combinations are in tab ‘Scenario 7a’ of the SPS list of biocide active substances
On 1 March 2028 these active substances will become ‘no longer supported’ in GB. This means that from 1 March 2028, biocidal products containing these active substances in the relevant product type can be made available on the market, subject to national rules, until a non-approval decision is made.
7b. GB status is under review
In GB the active substances are currently ‘under review’ for the listed product types by HSE as part of the GB Review Programme and may be used in biocidal products, subject to national rules.
The affected active substance/product type combinations are in tab ‘Scenario 7b’ of the SPS list of biocide active substances
On 1 March 2028 these active substances will become no longer supported in GB. This means that from 1 March 2028, biocidal products containing any of these active substances in the relevant product type can continue to be made available on the market, subject to national rules, until a non-approval decision is made.
If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of the active substance/product type combinations listed, email [email protected].
8. EU status is notified
All the active substance/product type combinations in this scenario have been supported following open invitation in the EU.
On 1 March 2028 these active substances will become ‘notified’ in GB. This means that products containing any active substances that are notified for the relevant product type can be made available on the market subject to national rules.
If these active substance/product type combinations are important to you, consider contacting the notifier to let them know. You may even be able to join them in supporting the active substance. You can check the ECHA list of notifications to see who the notifier is.
The following GB active substance statuses have been identified:
8a. GB status is not approved
In GB, this status means that the active substances are not approved for use in biocidal products of the listed product types following a non-approval decision. Products containing these active substance/product type combinations should not be currently supplied in GB.
The affected active substance/product type combinations are in tab ‘Scenario 8a’ of the SPS list of biocide active substances
On 1 March 2028 these active substances will become ‘notified’ in GB. This means that products containing these active substances for the relevant product type can be made available on the market, subject to national rules.
Guidance on the applicability of Article 89 transitional provisions will be communicated when available.
8b. GB status is under review
In GB these active substances are currently ‘under review’ for the listed product types by HSE as part of the GB Review Programme and may be used in biocidal products, subject to national rules.
The affected active substance/product type combinations are in tab ‘Scenario 8b’ of the SPS list of biocide active substances
On 1 March 2028 these active substances will become ‘notified’ in GB. This means that products containing these active substances for the relevant product type can be made available on the market, subject to national rules.
9. EU status is open invitation
The active substance/product type combinations in this scenario are currently open for invitation to take over the role of participant in the EU Review Programme.
On 1 March 2028 this status will apply to these active substance/product type combinations in GB. This means that products containing these active substances that are at open invitation for the relevant product type can be made available on the market subject to national rules.
If any of these active substance/product type combinations are important to you, consider supporting the active substance in the EU. If a notification to take over the role of participant is not submitted, the active substance/product type combination will be subject to an EU non-approval decision.
Please note that open invitations are time limited. The deadlines are provided on the ECHA website. Once the open invitation closes, depending on whether a notification was submitted or not, the active substance/product type combination will move scenarios. These will typically be scenario 8; notified or scenario 7; no longer supported.
The following GB active substance statuses have been identified:
9a. GB status is under review
In GB these active substances are currently ‘under review’ for the listed product types by HSE as part of the GB Review Programme and may be used in biocidal products, subject to national rules.
The affected active substance/product type combinations are in tab ‘Scenario 9a’ of the SPS list of biocide active substances
On 1 March 2028 these active substance/product type combinations in GB will be open for invitation to take over the role of participant (depending on the open invitation closing date). This means that products containing these active substances that are at open invitation for the relevant product type can be made available on the market subject to national rules.
If any of these active substance/product type combinations are important to you, consider supporting the active substance in the EU. If a notification to take over the role of participant is not submitted, the active substance/product type combination will be subject to an EU non-approval decision.
Be aware that the deadline for supporting an active substance under EU BPR may fall before 1 March 2028 when the SPS Agreement applies. Therefore, you may need to take action to support the active under the EU BPR before the GB status changes.
9b. GB status is no longer supported
This means in GB biocidal products containing active substances that are no longer supported for the relevant product type can continue to be made available on the market, until a GB non-approval decision is published. Due to the SPS Agreement, we do not expect any GB BPR non-approval decisions to be made for these active substances.
The affected active substance/product type combinations are in tab ‘Scenario 9b’ of the SPS list of biocide active substances
On 1 March 2028 these active substance/product type combinations in GB will be open for invitation to take over the role of participant (depending on the open invitation closing date). This means that products containing these active substances that are at open invitation for the relevant product type can be made available on the market subject to national rules.
If any of these active substance/product type combinations are important to you, consider supporting the active substance in the EU. If a notification to take over the role of participant is not submitted, the active substance/product type combination will be subject to an EU non-approval decision.
Be aware that the deadline for supporting an active substance under EU BPR may fall before 1 March 2028 when the SPS Agreement applies. Therefore, you may need to take action to support the active under the EU BPR before the GB status changes.
9c. GB status is not approved
In GB, this status means that the active substance is not approved for use in biocidal products of the listed product types following a non-approval decision.
Products containing these active substance/product type combinations should not be currently supplied in GB unless they are in a phase-out period.
The affected active substance/product type combinations are in tab ‘Scenario 9c’ of the SPS list of biocide active substances
On 1 March 2028 these active substance/product type combinations in GB will be open for invitation to take over the role of participant (depending on the open invitation closing date). This means that products containing these active substances that are at open invitation for the relevant product type can be made available on the market subject to national rules.
Guidance on the applicability of Article 89 transitional provisions will be communicated when available.
If any of these active substance/product type combinations are important to you, consider supporting the active substance in the EU. If a notification to take over the role of participant is not submitted the active substance/product type combination will be subject to an EU non-approval decision.
Be aware that the deadline for supporting an active under EU BPR may fall before 1 March 2028 when the SPS Agreement applies. Therefore, you may need to take action to support the active under the EU BPR before the GB status changes.
10. EU status is application cancelled
This status occurs when an application for a simplified active substance was made but was then withdrawn by the applicant. Biocidal products containing this active substance should not be on the EU market. The ECHA active substance database uses the status ‘cancelled application’.
The following GB active substance statuses have been identified:
10a. GB status is under assessment
This means in GB, biocidal products containing these active substances cannot be placed on the market while the assessment is underway.
In GB an article treated with a biocidal product containing these active substances may be placed on the market.
The affected active substance/product type combinations are in tab ‘Scenario 10a’ of the SPS list of biocide active substances
On 1 March 2028 these active substances will have the status ‘cancelled application’. From 1 March 2028, biocidal products containing these active substances, and articles treated with them, are not allowed to be placed on the market. Existing treated articles already in the supply chain before this date can continue to be made available and used in GB.